Showing results (51-60 of 129) with videos related to
Sort By:
Pageof 13
Cancer Letters|February 23, 2011
Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cellsChristian Kellner, Joerg Bruenke, Heike Horner, et al.Viruses|April 27, 2024
Combining Cellular Immunization and Phage Display Screening Results in Novel, FcγRI-Specific AntibodiesSteffen Krohn, Tosca Holtrop, Arianne M Brandsma, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cellsYvonne Guettinger, Karin Barbin, Matthias Peipp, et al.Journal of Molecular Medicine (Berlin, Germany)|August 12, 2025
Targeting mutated KRAS by HLA-A*02:01 restricted anti-KRAS TCR-mimic CAR and bispecific T cell engagerSaber Ebrahimi, Benedikt J Lohnes, Shamsul A Khan, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2011
Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killingStefan Lohse, Stefanie Derer, Thomas Beyer, et al.Molecular Cancer Therapeutics|November 2, 2021
The Novel Dual Topoisomerase Inhibitor P8-D6 Shows Anti-myeloma Activity In Vitro and In VivoKatja Klausz, Christian Kellner, Carina Lynn Gehlert, et al.Methods in Molecular Biology (Clifton, N.J.)|May 13, 2026
Combination of Fc-Protein Engineering Strategies: Design and Evaluation of Antibody Effector FunctionsCarina Lynn Gehlert, Steffen Krohn, Dorothee Winterberg, et al.Marine Life Science & Technology|May 26, 2026
Novel vanadium-dependent haloperoxidases from macroalgae and their expression in response to biotic and abiotic stressors in Saccharina latissimaTimo Jensen, Mira Wilkens, Holger Rehmann, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cellsChristian Kellner, Joerg Bruenke, Julia Stieglmaier, et al.British Journal of Haematology|July 21, 2005
Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16)Joerg Bruenke, Karin Barbin, Susanne Kunert, et al.Pageof 13